|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Amneal Pharmaceuticals, Inc.
| | | Phone: | (631) 952-0214 | Fax: | (631) 775-2505 | Year Established: | 2002 | Ticker: | AMRX | Exchange: | NYSE | Main Contact: | Jim Luce, Executive VP, Sales & Marketing | | Other Contacts: | Bryan M. Reasons, Senior VP & CFO Deb M. Penza, Senior VP, Chief Compliance Officer Sheldon Hirt, Senior VP, General Counsel Scott L. Hunter, VP, Specialty Sales and Marketing Miguel Gomez, Senior VP, Technical Operations Shankar Hariharan, Ph.D., Executive VP & CSO Joseph Greer, Senior VP, Global Quality Management Andrew S. Boyer, Executive VP, Commercial Operations Robert Stewart, President
| | Company Description | Amneal Pharmaceuticals is a U.S.-based developer and manufacturer of high quality generic pharmaceuticals globally. The Company owns and operates manufacturing, R&D, packaging, sales and distribution facilities throughout the U.S. and abroad. | |
|
|
|
|
|